Drug Shortage Report for CANDESARTAN/HCTZ
| Report ID | 240722 |
| Drug Identification Number | 02394804 |
| Brand name | CANDESARTAN/HCTZ |
| Common or Proper name | CANDESARTAN/HCTZ |
| Company Name | SANIS HEALTH INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL |
| Strength(s) | 12.5MG 16MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 100 |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-10-21 |
| Estimated end date | Unknown |
| Actual end date | 2025-04-01 |
| Shortage status | Resolved |
| Updated date | 2025-04-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v17 | 2025-04-02 | English | Compare |
| v16 | 2025-04-01 | French | Compare |
| v15 | 2025-04-01 | English | Compare |
| v14 | 2025-04-01 | English | Compare |
| v13 | 2025-01-29 | French | Compare |
| v12 | 2025-01-29 | English | Compare |
| v11 | 2025-01-22 | French | Compare |
| v10 | 2025-01-22 | English | Compare |
| v9 | 2025-01-08 | French | Compare |
| v8 | 2025-01-08 | English | Compare |
| v7 | 2024-12-11 | French | Compare |
| v6 | 2024-12-11 | English | Compare |
| v5 | 2024-11-11 | French | Compare |
| v4 | 2024-11-11 | English | Compare |
| v3 | 2024-10-22 | English | Compare |
| v2 | 2024-10-21 | French | Compare |
| v1 | 2024-10-21 | English | Compare |
Showing 1 to 17 of 17